Common Side Effects Across Statins
Lipitor (atorvastatin) shares the most frequent side effects with other statins like simvastatin (Zocor), rosuvastatin (Crestor), pravastatin (Pravachol), and lovastatin (Mevacor): muscle pain (myalgia, 1-10% of users), headache (2-7%), nausea (2-5%), diarrhea (3-5%), and elevated liver enzymes (0.5-3%). These occur at similar rates, with no statin consistently outperforming others in head-to-head trials for tolerability.[1][2]
Muscle-Related Risks: Lipitor vs. High-Potency Options
Lipitor causes rhabdomyolysis—a severe muscle breakdown—in about 1 in 10,000 patients, comparable to simvastatin and lovastatin. Rosuvastatin (Crestor) has a slightly higher reported rate (around 3 per 10,000), linked to its potency, while pravastatin shows the lowest (under 1 per 10,000). A 2019 meta-analysis of 135 trials found Lipitor's myopathy risk odds ratio at 1.07 (similar to generic statins), but higher doses amplify it across all.[3][4]
Liver and Kidney Concerns
All statins raise ALT/AST levels in 0.5-2% of users, with Lipitor matching rosuvastatin at the upper end; pravastatin has the mildest impact. Kidney issues like proteinuria are more common with rosuvastatin (up to 10% at high doses) than Lipitor (under 1%). Diabetes risk increases slightly with all (9% relative rise per 1 mmol/L LDL drop), but Lipitor and rosuvastatin show marginally higher odds (1.09-1.25) than pravastatin (1.00).[2][5]
How Lipitor Stacks Up by Specific Competitor
- Vs. Crestor (rosuvastatin): Crestor edges out on potency but has more diabetes signals and proteinuria; Lipitor reports fewer neurological effects like insomnia.[1][3]
- Vs. Zocor (simvastatin): Similar profiles, but simvastatin interacts more with drugs like amlodipine, raising myopathy risk 10-fold at 80mg.[4]
- Vs. Pravachol (pravastatin): Pravastatin is "cleanest" for muscles and liver, ideal for elderly patients; Lipitor is more effective at LDL reduction.[2]
- Vs. generics like lovastatin: Lipitor has better bioavailability, leading to fewer GI complaints but similar overall dropout rates (2-4%).[1]
Factors Influencing Side Effects
Dose matters most—high-intensity statins like Lipitor 40-80mg or Crestor 20-40mg double muscle risks vs. low doses. Genetics (SLCO1B1 variants) predict statin intolerance in 5-10% of users, equally across types. Women and Asians face 1.5-2x higher myopathy odds with any statin.[3][5]
Sources
[1] FDA Lipitor Label
[2] FDA Statin Class Labels Comparison
[3] Lancet Meta-Analysis on Statin Safety (2019)
[4] NEJM Statin Myopathy Review (2017)
[5] JAMA Diabetes Risk with Statins (2011)